AGENDA
After this event participants should be able to:
-
Discuss the dynamic progress in surgical therapy and differences among robotic and laparoscopic surgeries
-
Describe the clinical benefits of earlier treatment of patients with metastatic hormonesensitive prostate cancer (mHSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) and the consequences of disease progression
-
Discuss the impact of new data on treatment and management decisions for individual patients with localized PC, mHSPC and nmCRPC
Time
|
Session
|
Faculty
|
17:00
|
Welcome and introduction to advanced PC disease landscape
|
Prof. Mindaugas Jievaltas
|
17:15
|
Can laparoscopic radical prostatectomy match robotic?
|
Prof. Milan Hora
|
17:35
|
Is ADT alone still enough in mHSPC patients?
|
Prof. Bertrand Tombal
|
17:55
|
Management of nmCRPC
|
Prof. Boris Hadaschik
|
18:15 - 18:30
|
Panel discussion & Summary
|
All
|
THE AUSPICIES
The Committees of the Czech Urological Society and Lithuanian Urologist Association have approved the auspices of this educational event.
Date of preparation: August 2020
CP-179169